Newborn screening compared to clinical identification of biochemical genetic disorders

Area of Science:

• Biochemistry
• Genetics
• Pediatrics

Background:

• Inherited metabolic diseases (IMDs) are a group of genetic disorders.
• Early diagnosis and intervention are critical for managing IMDs.
• Screening programs aim to identify IMDs before clinical symptoms manifest.

Purpose of the Study:

• To compare outcomes for patients with IMDs diagnosed through newborn screening versus clinical identification.
• To assess differences in hospitalization rates, intellectual disability, and parental stress between the two diagnostic groups.

Main Methods:

• Retrospective comparison of two patient cohorts: 28 diagnosed by screening and 17 by clinical means.
• Patients had conditions including homocystinuria, galactosaemia, maple syrup urine disease, and biotinidase deficiency.
• Data collected on hospitalization rates, intellectual disability, and parental-reported stress and needs.

Main Results:

• Hospitalization rates were similar between screening-diagnosed and clinically-diagnosed patients.
• Patients diagnosed clinically exhibited a higher incidence of mental retardation.
• Parents of clinically diagnosed patients reported greater stress and difficulty meeting their child's needs.

Conclusions:

• Newborn screening for IMDs leads to better developmental outcomes and reduced family burden compared to clinical diagnosis.
• Early detection through screening is vital for mitigating long-term complications of IMDs.
• Screening programs offer significant advantages in managing inherited metabolic diseases.